Comparative Pharmacology
Head-to-head clinical analysis: CALCITRIOL versus ENSTILAR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCITRIOL versus ENSTILAR.
CALCITRIOL vs ENSTILAR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcitriol, the active form of vitamin D, binds to vitamin D receptors (VDR) in target tissues, modulating gene transcription. It increases intestinal calcium and phosphate absorption, enhances renal tubular reabsorption of calcium, and promotes bone mineralization by stimulating osteoblast activity.
ENSTILAR is a combination of calcipotriene (a vitamin D analog) and betamethasone dipropionate (a corticosteroid). Calcipotriene binds to vitamin D receptors, modulating cell proliferation and differentiation. Betamethasone suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis.
0.25-0.5 mcg orally once daily, may increase by 0.25 mcg/day at 4-8 week intervals; maximum 2 mcg/day.
Apply to affected area once daily for up to 4 weeks. Maximum 100 g/day or 30 g/week. Not for use on face, axillae, or groin.
None Documented
None Documented
Clinical Note
moderateCalcitriol + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Fluconazole
5–8 hours (terminal) in normal renal function; prolonged up to 18–24 hours in chronic kidney disease (CKD) due to reduced clearance.
Calcipotriol: terminal half-life ~12 hours. Betamethasone dipropionate: terminal half-life ~16-22 hours. Clinically, this supports once-daily application.
Renal (fecal after biliary excretion of metabolites): ~10% unchanged in urine; ~70% as metabolites in feces via bile.
Calcipotriol is primarily excreted via bile/feces (approximately 70% of absorbed dose). Betamethasone dipropionate is mainly excreted renally (60-70% as metabolites) and up to 20-30% via feces. For the combination, renal excretion of betamethasone metabolites predominates, with fecal excretion of calcipotriol.
Category A/B
Category C
Vitamin D Analog
Topical Corticosteroid and Vitamin D Analog
"The metabolism of Fluconazole can be decreased when combined with Calcitriol."